Suchergebnisse - "Lauletta, Antonio"

1

Distal upper limb involvement in myasthenia-myositis association

von: Lauletta, Antonio

2022, in: Neurological sciences

Wird geladen...
2

Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause?

von: Lauletta, Antonio

2023, in: Neurological sciences

Wird geladen...
3

Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors

von: Fionda, Laura

2023, in: Neurological sciences

Wird geladen...
4

Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up

von: Fionda, Laura

2021, in: Journal of neurology

Wird geladen...
5

High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP

von: Leonardi, Luca

2021, in: Neurological sciences

Wird geladen...
6

Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study

von: Fionda, Laura

2024, in: Journal of neurology

Wird geladen...
7

Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation

von: Leonardi, Luca

2021, in: Neurological sciences

Wird geladen...
8

Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients

von: Fionda, Laura

2023, in: Neurological sciences

Wird geladen...
9

Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies

von: Fionda, Laura

2022, in: Journal of neurology

Wird geladen...
10

Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN)

von: Galosi, Eleonora

2024, in: Neurological sciences

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!